Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 February 2007, Vol. 109, No. 4, pp. 1507-1514.
Prepublished online as a Blood First Edition Paper on November 2, 2006; DOI 10.1182/blood-2005-03-024463.


This Article
Right arrow Full Text (PDF)
Right arrow Supplemental Table
Right arrow All Versions of this Article:
blood-2005-03-024463v1
109/4/1507    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Satta, N.
Right arrow Articles by de Moerloose, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Satta, N.
Right arrow Articles by de Moerloose, P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted March 18, 2005
Accepted September 25, 2006

The role of TLR2 in the inflammatory activation of mouse fibroblasts by human antiphospholipid antibodies

Nathalie Satta, Sylvie Dunoyer-Geindre, Guido Reber, Richard J Fish, Francoise Boehlen, Egbert KO Kruithof, and Philippe de Moerloose*

Division of Angiology & Hemostasis, University Hospital, Faculty of Medicine, Geneva, Switzerland

* Corresponding author; email: philippe.demoerloose{at}hcuge.ch.

Antiphospholipid antibodies (APLA) promote inflammatory and procoagulant responses in endothelial cells and monocytes. Previous studies have shown that MyD88, TRAF6 and NF-{kappa}B mediate cell activation by APLA. These intermediates are also employed by Toll-like receptors (TLR). We investigated the role of TLRs in the cellular response to APLA. IgG were isolated from the plasma of five antiphospholipid syndrome patients and immunopurified anti-{beta}2-glycoprotein 1 IgG from a sixth patient. Control IgG was obtained from a pool of healthy donor plasmas negative for APLA. Wild-type mouse embryonic fibroblasts (EF) and EF deficient in TLR1, TLR2, TLR4 or TLR6 were incubated with APLA, anti-{beta}2-glycoprotein 1 IgG or control IgG. Upon incubation with the patient IgG, but not control IgG, a significant increase in mRNA levels of the inflammatory marker proteins MCP-1, ICAM-1 and IL-6 as well as IL-6 secretion was observed in wild-type EF, whereas TLR2-deficient EF did not respond. Responses in TLR1- and TLR6-deficient EF were decreased and those in TLR4-deficient EF comparable to those in wild-type EF. Overexpression of human TLR2 in the TLR2-deficient EF restituted the response to patient IgG. Our results imply that TLR2 plays a role in mouse fibroblast activation by APLA.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
LupusHome page
E Raschi, M. Borghi, C Grossi, V Broggini, S Pierangeli, and P. Meroni
Toll-like receptors: another player in the pathogenesis of the anti-phospholipid syndrome
Lupus, October 1, 2008; 17(10): 938 - 943.
[Abstract] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2006 by American Society of Hematology         Online ISSN: 1528-0020